Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).

By J. Lefaucheur, N. André-Obadia, Andrea Antal, S. Ayache, C. Baeken, D. Benninger, R. Cantello, M. Cincotta, M. Carvalho, D. Ridder and 23 more. Clinical Neurophysiology, 2014

1,955 citations recorded by the source corpus.

A group of European experts was commissioned to establish guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until March 2014, regarding pain, movement disorders, stroke, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, consciousness disorders, tinnitus, depression, anxiety disorders, obsessive-compulsive disorder, schizophrenia, craving/addiction, and conversion. Despite unavoidable inhomogeneities, there is a sufficient body of evidence to accept with level A (definite efficacy) the analgesic effect of high-frequency (HF) rTMS of the primary motor cortex (M1) contralateral to the pain and the antidepressant effect of HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC). A Level B recommendation (probable efficacy) is proposed for the antidepressant effect of low-frequency (LF) rTMS of the right DLPFC, HF-rTMS of the left DLPFC for the negative symptoms of schizophrenia, and LF-rTMS of contralesional M1 in chronic motor stroke. The effects of rTMS in a number of indications reach level C (possible efficacy), including LF-rTMS of the left temporoparietal cortex in tinnitus and auditory hallucinations. It remains to determine how to optimize rTMS protocols and techniques to give them relevance in routine clinical practice. In addition, professionals carrying out rTMS protocols should undergo rigorous training to ensure the quality of the technical realization, guarantee the proper care of patients, and maximize the chances of success. Under these conditions, the therapeutic use of rTMS should be able to develop in the coming years.

Subfields: Cognitive Neuroscience, Neurology

View Paper: https://www.semanticscholar.org/paper/53288d0355fbd3028d5ef92f256053eb0e8026b6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cognitive Neuroscience

In Neurology

Citations in the corpus

Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee (2015, background): “First, all studies consistently reported the absence of any significant analgesic effect of LF rTMS of M1 delivered contralateral to the pain side (Lefaucheur et al., 2001a, 2006b, 2008, 2014; André-Obadia et al., 2006; Saitoh et al., 2007).”
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018) (2019, neutral): “Contents lists available at ScienceDirect Clinical Neurophysiology journal homepage: www.elsevier .com/locate /c l inph Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018) https://doi.org/10.1016/j.clinph.2019.11.002 1388-245”
Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS). (2015, background): “been developed and include the circular coil, figure-of-eight coil, double-cone coil, air-cooled coil and, more recently, the Hesed coil [21], c-Core coil and circular crown coil [7].”
Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). (2017, methodology): “This is the case for rTMS (Lefaucheur et al., 2014) and even more for tDCS.”